anything is possible but the PR isn't ground breaking. A good step of course, but nothing that says AMBS is truly onto something. I think the addition of a big pharma as part of partnership would have been a loud and clear statement that AMBS' MANF is something worthy to invest in. So far, no BPs want to be part of the MANF story. Let's see if that changes soon.